Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Pfizer
NeoImmuneTech
Alterome Therapeutics, Inc.
ToLymph Inc.
Hoffmann-La Roche
Nuvectis Pharma, Inc.
AstraZeneca
Istituto Oncologico Veneto IRCCS
AstraZeneca
Avenzo Therapeutics, Inc.